tiprankstipranks
Scinai Immunotherapeutics (SCNI)
NASDAQ:SCNI
US Market

Scinai Immunotherapeutics (SCNI) Stock Forecast & Price Target

335 Followers
See the Price Targets and Ratings of:

SCNI Analyst Ratings

Currently, no data available
Based on NaN analysts giving stock ratings to
Scinai
Immunotherapeutics
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

SCNI Stock 12 Month Forecast

There Are No Analyst Ratings for SCNI In The Last 3 Months.
Highest Price TargetAverage Price TargetLowest Price Target
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

SCNI Financial Forecast

SCNI Earnings Forecast

The previous quarter’s earnings for SCNI were -$4.74.
The previous quarter’s earnings for SCNI were -$4.74.

SCNI Sales Forecast

The previous quarter’s earnings for SCNI were $277.29K.
The previous quarter’s earnings for SCNI were $277.29K.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks - xAI Analyst forecast on SCNI
TipRanks - xAI
TipRanks - xAI
$0.98$0.59
Hold
-24.49%
Downside
Reiterated
04/07/26
AI Generated ArticleAI Generated Article
TipRanks - DeepSeek Analyst forecast on SCNI
TipRanks - DeepSeek
TipRanks - DeepSeek
$0.99$0.59
Hold
-24.87%
Downside
Reiterated
04/07/26
AI Generated ArticleAI Generated Article
TipRanks - Anthropic Analyst forecast on SCNI
TipRanks - Anthropic
TipRanks - Anthropic
$0.96$0.58
Sell
-26.15%
Downside
Downgraded
04/07/26
AI Generated ArticleAI Generated Article
TipRanks - Google Analyst forecast on SCNI
TipRanks - Google
TipRanks - Google
$1$0.57
Sell
-26.54%
Downside
Downgraded
04/07/26
AI Generated ArticleAI Generated Article
TipRanks - PerPlexity Analyst forecast on SCNI
TipRanks - PerPlexity
TipRanks - PerPlexity
$0.96$0.56
Sell
-28.85%
Downside
Downgraded
04/07/26
AI Generated ArticleAI Generated Article
TipRanks - OpenAI Analyst forecast on SCNI
TipRanks - OpenAI
TipRanks - OpenAI
$0.98$0.59
Hold
-24.10%
Downside
Reiterated
04/07/26
AI Generated ArticleAI Generated Article
Analyst Type
Any
Any
AI Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks - xAI Analyst forecast on SCNI
TipRanks - xAI
TipRanks - xAI
$0.98$0.59
Hold
-24.49%
Downside
Reiterated
04/07/26
AI Generated ArticleAI Generated Article
TipRanks - DeepSeek Analyst forecast on SCNI
TipRanks - DeepSeek
TipRanks - DeepSeek
$0.99$0.59
Hold
-24.87%
Downside
Reiterated
04/07/26
AI Generated ArticleAI Generated Article
TipRanks - Anthropic Analyst forecast on SCNI
TipRanks - Anthropic
TipRanks - Anthropic
$0.96$0.58
Sell
-26.15%
Downside
Downgraded
04/07/26
AI Generated ArticleAI Generated Article
TipRanks - Google Analyst forecast on SCNI
TipRanks - Google
TipRanks - Google
$1$0.57
Sell
-26.54%
Downside
Downgraded
04/07/26
AI Generated ArticleAI Generated Article
TipRanks - PerPlexity Analyst forecast on SCNI
TipRanks - PerPlexity
TipRanks - PerPlexity
$0.96$0.56
Sell
-28.85%
Downside
Downgraded
04/07/26
AI Generated ArticleAI Generated Article
TipRanks - OpenAI Analyst forecast on SCNI
TipRanks - OpenAI
TipRanks - OpenAI
$0.98$0.59
Hold
-24.10%
Downside
Reiterated
04/07/26
AI Generated ArticleAI Generated Article
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Scinai Immunotherapeutics

3 Months
xxx
Success Rate
0/1 ratings generated profit
0%
Average Return
-14.40%
downgraded a xxx
rating 6 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 0.00% of your transactions generating a profit, with an average return of -14.40% per trade.
1 Year
Anthropic BiotechnologyTipRanks - Anthropic
Success Rate
0/1 ratings generated profit
0%
Average Return
-14.40%
downgraded a sell rating 6 days ago
Copying Anthropic Biotechnology's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -14.40% per trade.
2 Years
xxx
Success Rate
0/1 ratings generated profit
0%
Average Return
-14.40%
downgraded a xxx
rating 6 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -14.40% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

SCNI Analyst Recommendation Trends

Rating
Jan 25
Dec 25
Jan 26
Feb 26
Apr 26
Strong Buy
0
0
0
0
0
Buy
0
0
0
0
0
Hold
3
3
19
22
25
Sell
2
2
4
4
6
Strong Sell
0
0
0
0
0
total
5
5
23
26
31
In the current month, SCNI has received 0 Buy Ratings, 25 Hold Ratings, and 6 Sell Ratings. SCNI average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.

SCNI Stock Forecast FAQ

What is SCNI’s average 12-month price target, according to analysts?
Currently, no data Available
What is SCNI’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for SCNI, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is SCNI a Buy, Sell or Hold?
      Currently, no data Available
      What is Scinai Immunotherapeutics’s price target?
      Currently, no data Available
      What do analysts say about Scinai Immunotherapeutics?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of SCNI?
      Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.